glp 1 asa guidelines 🔸 Should GLP-1 RAs be continued preprocedurally? 🔸 Who should stop a GLP-1 RA preoperatively? 🔸 Which patients should have their procedures postponed? Read: https://doi.org/10.1097/01.ASM.0001125664.22893.9f Frontiers | Mechanisms of action

Planning for potential coverage disruptions by identifying compounded alternatives in advance prevents forced abrupt discontinuation

Anecdotal evidence suggests that the change in taste some people experience is actually the smell of burps

According to Harvard Health Publishing , some users have lost over 20% of their body weight in a yeara rate that raises red flags around strength, metabolism, and long-term resilience

1 This translates into a lower risk of hypoglycemia compared to other diabetes treatment options like sulfonylureas and insulin

However, insufficient evidence exists to justify the discontinuation of GLP-1 RAs before the procedure, and the ideal cessation timing for these agents remains indeterminate

KFF reports that policymakers and insurers are increasingly evaluating strategies to manage the financial impact of GLP-1 coverage, particularly within Medicare and Medicaid programs where long-term costs could become significant